3004.90.92.46/Bupropion HCl XL 150mg Tablets/Canada

Bupropion HCl XL 150mg Tablets from Canada

Bupropion hydrochloride extended-release 150mg tablets treat depression and smoking cessation as atypical antidepressants. Classified under HTS 3004.90.92.46 for psychotherapeutic agents in measured retail doses affecting the central nervous system.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Provide seizure risk labeling and contraindication information per FDA

• Ensure 24-hour release profile documentation for XL formulations

• Batch testing for NDMA impurities required under current FDA guidance

Bupropion HCl XL 150mg Tablets from Canada — Import Duty Rate | HTS 3004.90.92.46